Wall Street Experts
| Wartość aktywów (mln USD): | 78 | |||||||||||
| Liczba spółek: | 41 | |||||||||||
| Stopa dywidendy: | - % | |||||||||||
| Opłata za zarządzanie:: | 0.5 % | |||||||||||
| Klasa aktywów: | Equity |
ISIN: US37954Y4347
Wystawca ETF: Global X| Nazwa | Symbol | Klasa_aktywów | Wartość_aktywów | 5D | 1M | 3M | 6M | 2024 | 1R | 3L | 5L | 10L |
|---|
| Sektor | Udział % |
|---|---|
| Technologie Medyczne | 99.0 |
| Usługi Zdrowotne | 0.7 |
| Różne | 0.3 |
| Gotówka | 0.1 |
| Nazwa firmy | Symbol | Wartość | Udział % w portfelu | Ilość akcji |
|---|---|---|---|---|
| NATERA INC | NTRA | 2 947 281 | 6.6 | 22 016 |
| VERACYTE INC | VCYT | 2 326 827 | 5.2 | 80 374 |
| QIAGEN N.V. | QGEN | 2 305 318 | 5.2 | 60 254 |
| BIOMARIN PHARMAC | BMRN | 2 243 841 | 5.1 | 37 236 |
| ALNYLAM PHARMACE | ALNY | 2 076 869 | 4.7 | 8 810 |
| BIONTECH SE-ADR | BNTX | 2 068 206 | 4.7 | 23 489 |
| GENSCRIPT BIOTECH CORP | 1548.HK | 2 033 649 | 4.6 | 1 296 018 |
| AGILENT TECHNOLOGIES INC | A | 2 023 332 | 4.6 | 19 644 |
| BIO-TECHNE CORP | TECH | 1 946 378 | 4.4 | 37 633 |
| LEGEND BIOTECH CORP-ADR | LEGN | 1 899 825 | 4.3 | 59 351 |
| CRISPR THERAPEUTICS AG | CRSP | 1 850 504 | 4.2 | 56 677 |
| GILEAD SCIENCES INC | GILD | 1 600 170 | 3.6 | 14 920 |
| ULTRAGENYX PHARM | RARE | 1 546 035 | 3.5 | 47 673 |
| AVIDITY BIOSCIENCES INC | RNA | 1 526 180 | 3.4 | 57 440 |
| ARROWHEAD PHARMA | ARWR | 1 398 855 | 3.2 | 130 979 |
| ILLUMINA INC | ILMN | 1 354 309 | 3.0 | 18 262 |
| BEAM THERAPEUTICS INC | BEAM | 1 351 700 | 3.0 | 88 520 |
| VERTEX PHARM | VRTX | 1 317 070 | 3.0 | 2 775 |
| MODERNA INC | MRNA | 1 226 071 | 2.8 | 48 828 |
| SAREPTA THERAPEUTICS INC | SRPT | 1 094 043 | 2.5 | 20 100 |
| CAREDX INC | CDNA | 1 052 507 | 2.4 | 60 909 |
| 10X GENOMICS INC-CLASS A | TXG | 919 138 | 2.1 | 123 044 |
| MYRIAD GENETICS INC | MYGN | 877 381 | 2.0 | 107 919 |
| INTELLIA THERAPEUTICS INC | NTLA | 816 703 | 1.8 | 123 183 |
| VIR BIOTECHNOLOGY INC | VIR | 607 170 | 1.4 | 108 812 |
| ROCKET PHARMACEU | RCKT | 529 899 | 1.2 | 103 496 |
| UNIQURE NV | QURE | 497 799 | 1.1 | 55 558 |
| FULGENT GENETICS INC | FLGT | 410 743 | 0.9 | 24 362 |
| PACIFIC BIOSCIEN | PACB | 393 622 | 0.9 | 320 018 |
| REGENXBIO INC | RGNX | 345 100 | 0.8 | 54 865 |
| 2SEVENTY BIO INC | TSVT | 302 608 | 0.7 | 61 133 |
| MARAVAI LIFESC-A | MRVI | 281 364 | 0.6 | 145 033 |
| VERVE THERAPEUTICS INC | VERV | 279 091 | 0.6 | 77 097 |
| ALLOGENE THERAPEUTICS INC | ALLO | 251 022 | 0.6 | 174 321 |
| SANA BIOTECHNOLOGY INC | SANA | 226 900 | 0.5 | 153 311 |
| SANGAMO THERAPEUTICS INC | SGMO | 157 036 | 0.4 | 239 202 |
| EDITAS MEDICINE INC | EDIT | 100 825 | 0.2 | 97 889 |
| LYELL IMMUNOPHARMA INC | LYEL | 76 459 | 0.2 | 164 500 |
| CARIBOU BIOSCIENCES INC | CRBU | 75 841 | 0.2 | 98 816 |
| CASH | 43 076 | 0.1 | 43 077 | |
| OTHER PAYABLE & RECEIVABLES | 17 317 | 0.0 | 17 317 | |
| SCILEX HOLDING RESTRICTED | E | 583 | 0.0 | 226 071 |